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CARDIAC TRANSPLANTATION IN CHILDRE;: WITH 
CONGENITAL HEART DISEASE 
Daphne T. Hsu, Linda 5. Addonizio, Craig R. Smith, Eric A. Rose, 
Welton M. Gersony. Columbia University, New York, New York. 
Cardiac transplantation (CT) offers an alternative to high-risk 
corrective surgery in the pediatric pt with congenital heart disease 
(CHD) and depressed ventricular function. However, the outcome of 
these pts may be influenced by factors related to their CHD. 
We have performed CT in a total of 49 pediatric pts. 17 with CHD 
(mean age 9.4k6.7 yrs). The indication for CT was ventricular failure 
in 15117 pts: 12 pts had undergone previous cardiac surgery, 3 were 
unoperated. Two neonates were not felt to be candidates for surgical 
repair. Ten pts required pulmonary artery reconstruction, 8 pts had 
vansposed great vessels, 1 pt had dextrocardia and 1 pt had systemic 
and pulmonary venous anomalies. The 17 pts with CHD were 
compared to the 32 pts without CHD. 6/17 pts with CHD had 
PVRI>B, not significantly different from the 17/32 pts without CHD 
with PVRI>6. No significant difference in ischemic time (mean 
179&59 v. 168fs9 minutes), pt survival (mean 15f18 v. 2&17 
months), rejection incidence or infectious episodes was seen be- 
tween pts with and without CHD. 7/17 pts with CHD died (4 pts < 
3 mo. post-CT: 1 ofdonor failure, 2 of sepsis, 1 of acute rejection and 
3 pts > 3 mo. post-CT: 2 from rejection, 1 infection), this was not sig- 
nificantly different from the 1 l/32 pts without CHD who died. 
in summary, CHD did not adversely effect the outcome of 
pediatric patients following CT. CT should be considered in the 
patient in whom corrective surgery is felt to be high :isk due to the 
complexity of the CID or poor ventricular function. 
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We studied 20 consecutive pts with ischemic heart disease 
who underwent heterotopic heart transplantation (HTx) 
between January 1988 and June 1990. We performed 
hemodynamic studies and Doppler Echocardiography before 
and after heterotopic HTx, 10 and 30 days after #TX. 
After HTx, mean pulmonary artery pressure decreased from 
(mean +I- sd) 34 +I- 12 mmHg to 21 +/-lo (~~0.05) and 
pulmonary artery wedge pressure decreased from 22 +/- 9 to 
10 +/- 7 (p L 0.01); cardiac index increased from 1.3 +/- 0.5 
l/mn.m2 to 3.4 +I- 0.7 I/mn.m2 (p = 0.01). 
Native heart tricuspid regurgitation was found unchanged on 
Doppler color flow mapping and velocity assessement. 
Native heart mitral regurgitation significantly increased after 
HTx, from grade 0.8 +/- 0.4 to 1.7 +/- 0.6 (p = 0.02) 
Mild aortic regurgitation appeared after HTx in 10 pts. 
Native heart end-systolic and end-diastolic left ventricular 
diameters, left ventricular ejection fraction assessed by 2 
dimensional and TM echocardiography were found 
unchanged after HTx. 
l.After heterotopic HTx, an aortic regurgitation appeared in 
50% of our pts along with a significant increase of the mitral 
regurgitation of the native heart. 
2.These abnormalities might be related to the asynchronicity 
of the two parallel hearts 
3.These abnormalities do not prevent improvement of the 
hemodynamic status 
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Temporary left ventricular assist (NOVACOR) system (LVAS) has been 
utilized as a bridge to cardiac transplantation. To evaluate the potential of 
this mechanical device as a self-wntaiued pe 
parameters were measured in 7 male pts with A class IV biventri:ular 
cardiac failure (CHF) before and after LVAS implantation. 
before (range 1-36 days) and after (range 4-144 days) LVAS support were 
before (range 2-36 days) 
testing and measurement of peak oxygen consu 
after (range 34-123 days) LVAS implantation. 
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Temporary LVAS support improves cardiac hemodynamic 
function and exercise capacity in NYHA class IV CHF pts with 
biventricular failure. ‘obese favorable eKects on cardiac function support 
the development of a permanent implantable LVAS for pts with severe 
refractory CHF. 
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Anemia unresponsive to iron therapy occurs in some pts after 
cardiac transplant (Ctx) and does not appear to result from 
differences in immunosuppression. To determine whether these 
pts have depressed erythropoietin (Epo) production, Epo serum 
levels were measured in 53 Ctx pts between 6/90 and 8/90, who 
were >3 months after Ctx. All Ctx pts were on triple drug 
immunotherapy including azathioprine 2 mg/kg/day. The pts were 
divided into 3 groups according to hemoglobin level (Hb). 
Although Epo production should be increased in response to 
anemia, Epo levels were lowest in the lowest Hb group (Group 1). 
Serum crcatinine was higher in Group 1 than in Group 3, but did 
not reach significance (p = 0.10). 
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Epo levels are inappropriately low in Ctx pts with anemia, and may 
relate to renal effects of cyclosporine. It is not yet known whether 
such anemia will respond to therapy with Epo. 
